These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 1850549)

  • 1. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor.
    Kaplan DR; Hempstead BL; Martin-Zanca D; Chao MV; Parada LF
    Science; 1991 Apr; 252(5005):554-8. PubMed ID: 1850549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
    Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
    Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
    Sartore-Bianchi A; Ardini E; Bosotti R; Amatu A; Valtorta E; Somaschini A; Raddrizzani L; Palmeri L; Banfi P; Bonazzina E; Misale S; Marrapese G; Leone A; Alzani R; Luo D; Hornby Z; Lim J; Veronese S; Vanzulli A; Bardelli A; Martignoni M; Davite C; Galvani A; Isacchi A; Siena S
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26563355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired Resistance to the TRK Inhibitor Entrectinib in Colorectal Cancer.
    Russo M; Misale S; Wei G; Siravegna G; Crisafulli G; Lazzari L; Corti G; Rospo G; Novara L; Mussolin B; Bartolini A; Cam N; Patel R; Yan S; Shoemaker R; Wild R; Di Nicolantonio F; Bianchi AS; Li G; Siena S; Bardelli A
    Cancer Discov; 2016 Jan; 6(1):36-44. PubMed ID: 26546295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.
    Créancier L; Vandenberghe I; Gomes B; Dejean C; Blanchet JC; Meilleroux J; Guimbaud R; Selves J; Kruczynski A
    Cancer Lett; 2015 Aug; 365(1):107-11. PubMed ID: 26001971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences.
    Martin-Zanca D; Hughes SH; Barbacid M
    Nature; 1986 Feb 27-Mar 5; 319(6056):743-8. PubMed ID: 2869410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trk receptors use redundant signal transduction pathways involving SHC and PLC-gamma 1 to mediate NGF responses.
    Stephens RM; Loeb DM; Copeland TD; Pawson T; Greene LA; Kaplan DR
    Neuron; 1994 Mar; 12(3):691-705. PubMed ID: 8155326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p75 and Trk: a two-receptor system.
    Chao MV; Hempstead BL
    Trends Neurosci; 1995 Jul; 18(7):321-6. PubMed ID: 7571013
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Amatu A; Sartore-Bianchi A; Siena S
    ESMO Open; 2016; 1(2):e000023. PubMed ID: 27843590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease.
    Calissano P; Matrone C; Amadoro G
    Dev Neurobiol; 2010 Apr; 70(5):372-83. PubMed ID: 20186703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Trk family of neurotrophin receptors.
    Barbacid M
    J Neurobiol; 1994 Nov; 25(11):1386-403. PubMed ID: 7852993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma.
    Wang Y; Long P; Wang Y; Ma W
    Front Oncol; 2020; 10():593578. PubMed ID: 33330081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints.
    Zhao L; Lai Y; Jiao H; Huang J
    Nat Commun; 2024 Apr; 15(1):3225. PubMed ID: 38622181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic characteristics of three patients with congenital insensitivity to pain with anhidrosis: Case reports and a review of the literature.
    Cho JH; Hwang S; Kwak YH; Yum MS; Seo GH; Koh JY; Ju YS; Yoon JH; Kang M; Do HS; Kim S; Kim GH; Bae H; Lee BH
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2430. PubMed ID: 38581121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation therapies for pancreatic cancer.
    Buckley CW; O'Reilly EM
    Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):55-72. PubMed ID: 38415709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve Growth Factor Receptor Limits Inflammation to Promote Remodeling and Repair of Osteoarthritic Joints.
    Zhao L; Lai Y; Jiao H; Huang J
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the feasibility of chemotherapeutic and immunotherapeutic targets against non-small cell lung cancers: an update of resistant responses and recent combinatorial therapies.
    Malik P; Rani R; Solanki R; Patel VH; Mukherjee TK
    Explor Target Antitumor Ther; 2023; 4(5):850-895. PubMed ID: 37970206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.
    Vargas J; Pantouris G
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase separation underlies signaling activation of oncogenic NTRK fusions.
    Zhu T; Xie J; He H; Li H; Tang X; Wang S; Li Z; Tian Y; Li L; Zhu J; Zhu G
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2219589120. PubMed ID: 37812694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.